bone metastases
FDA Approves First Interchangeable Biosimilars to Xgeva and Prolia
The FDA approved the first interchangeable biosimilar to Prolia (denosumab) and Xgeva (denosumab). Sandoz’s ...
MARCH 6, 2024
Distant Mets Studied by Breast Cancer Subtype
Bone metastases occur more frequently in patients with hormone receptor (HR)-positive/HER2-negative breast cancer ...
JUNE 22, 2017
Load more